Retrospective Assessment of Cost Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S.
about
A 2015 global update on folic acid-preventable spina bifida and anencephaly.Fortification of condiments with micronutrients in public health: from proof of concept to scaling up.Adjusting Health Expenditures for Inflation: A Review of Measures for Health Services Research in the United States.Medical cost savings in Sakado City and worldwide achieved by preventing disease by folic acid fortification.Methotrexate and Valproic Acid Affect Early Neurogenesis of Human Amniotic Fluid Stem Cells from Myelomeningocele.Prenatal folic acid use associated with decreased risk of myelomeningocele: A case-control study offers further support for folic acid fortification in Bangladesh.Adding folic acid to corn Masa flour: Partnering to improve pregnancy outcomes and reduce health disparities.Recommendations of the Second Panel on Cost Effectiveness in Health and Medicine: A Reference, Not a Rule Book.Cost and Cost-Effectiveness Assessments of Newborn Screening for Critical Congenital Heart Disease Using Pulse Oximetry: A Review.Folic Acid Exposure Rescues Spina Bifida Aperta Phenotypes in Human Induced Pluripotent Stem Cell Model.The investment case for folic acid fortification in developing countries.How Economic Findings Can Inform Prevention Research in Cardiovascular Disease.Total prevention of folic acid-preventable spina bifida and anencephaly would reduce child mortality in India: Implications in achieving Target 3.2 of the Sustainable Development Goals
P2860
Q30061994-42F36133-B975-47EB-BD77-B2C80FDA503AQ38923627-ED1EBC1C-5863-4D66-8053-4D26277E17F1Q39016355-678D8538-0FDE-4442-A918-A2F60F0E9564Q39129432-EB517090-F173-4D78-9634-D507DFB16340Q43374976-E2074EE9-279D-4028-87A3-17E18DF1B5C5Q46301120-6F08D634-58E8-42AE-8D8A-243339EAA1FEQ47285581-2FAC12EE-B38A-40F9-9196-864ED62C35F1Q47552934-A1D41ED0-1DED-4BA6-9429-393D4631EF5EQ47708208-540B998B-88A0-4A24-BE7A-2F5EC510CBB3Q49260119-C6CC262F-BD10-430A-82A2-10AA39EBB1EFQ49831215-68259644-B1AF-4484-93D5-78F758809B23Q49889533-CA5146DF-2D61-4D27-9C89-E459EC7A57B7Q56669805-16796F73-6786-433C-B18D-05F783397E74
P2860
Retrospective Assessment of Cost Savings From Prevention: Folic Acid Fortification and Spina Bifida in the U.S.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Retrospective Assessment of Co ...... n and Spina Bifida in the U.S.
@en
type
label
Retrospective Assessment of Co ...... n and Spina Bifida in the U.S.
@en
prefLabel
Retrospective Assessment of Co ...... n and Spina Bifida in the U.S.
@en
P2093
P2860
P1476
Retrospective Assessment of Co ...... n and Spina Bifida in the U.S.
@en
P2093
J Mick Tilford
James E Kucik
Norman J Waitzman
P2860
P304
P356
10.1016/J.AMEPRE.2015.10.012
P433
P577
2015-12-22T00:00:00Z